Literature DB >> 8895386

Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.

T J Kieffer1, R S Heller, C G Unson, G C Weir, J F Habener.   

Abstract

Glucagon is insulinotropic, but it remains uncertain whether the insulinotropic action is mediated directly by glucagon receptors expressed on beta-cells or by cross-binding to the insulinotropic glucagon-like peptide-1 (GLP-1) receptor known to be expressed on beta-cells. Binding of [125I]glucagon to GLP-1 receptors and not to glucagon receptors has been reported in tumor-derived beta-cells (15). The objectives of the current study were to use receptor-binding techniques and a glucagon receptor-specific antiserum to determine whether glucagon receptors are present on beta-cells. Specific binding (7.2 +/- 0.8%) of [125I]GLP-1 to beta TC-3 cells was displaced equivalently with GLP-1 and exendin-(9-39) )Kd = 0.9 and 0.4 nM. respectively), whereas approximately 700-fold higher concentrations of glucagon were required for equal displacement (Kd = 400 nM). Binding of [125I]glucagon to beta TC-3 cells (approximately 1%) was displaced equivalently with 1 microM glucagon, GLP-1, or exendin-(9-39). These observations support earlier findings that beta TC-3 cells do not express functional glucagon receptors. However, specific binding of [125I]glucagon was observed on INS-1 cells (2.3 +/- 0.2%); this was displaced with glucagon (Kd = 1 nM), but not 1 microM GLP-1 or exendin-(9-39). To examine the distribution of glucagon receptors on native beta-cells, dispersed cultured rat islets were immunostained for glucagon, somatostatin, or insulin in combination with a polyclonal rabbit antiserum raised to an extracellular portion of the glucagon receptor (KD-14). The glucagon receptor antiserum colocalized staining with approximately 97% of immunoreactive insulin cells, 9% of immunoreactive glucagon cells, and 11% of immunoreactive somatostatin cells. Perfusion of the rat pancreas with concentrations of glucagon as low as 10(-12) M resulted in significant insulin release. These results suggest that whereas the tumor-derived beta-cell line beta TC-3 does not express functional glucagon receptors, INS-1 cells and isolated rat pancreatic beta-cells have specific glucagon receptors, as do a subpopulation of alpha- and delta-cells. A model is proposed for the role of glucagon in islet hormone secretion during feeding and fasting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895386     DOI: 10.1210/endo.137.11.8895386

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

Authors:  Kyle W Sloop; Julia Xiao-Chun Cao; Angela M Siesky; Hong Yan Zhang; Diane M Bodenmiller; Amy L Cox; Steven J Jacobs; Julie S Moyers; Rebecca A Owens; Aaron D Showalter; Martin B Brenner; Achim Raap; Jesper Gromada; Brian R Berridge; David K B Monteith; Niels Porksen; Robert A McKay; Brett P Monia; Sanjay Bhanot; Lynnetta M Watts; M Dodson Michael
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation.

Authors:  Patricia M Vuguin; Mamdouh H Kedees; Lingguang Cui; Yelena Guz; Richard W Gelling; Morris Nejathaim; Maureen J Charron; Gladys Teitelman
Journal:  Endocrinology       Date:  2006-04-20       Impact factor: 4.736

Review 3.  α-cell role in β-cell generation and regeneration.

Authors:  Joel F Habener; Violeta Stanojevic
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

4.  Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

Authors:  Hiroshi Yamamoto; Toshiro Kishi; Charlotte E Lee; Brian J Choi; Hui Fang; Anthony N Hollenberg; Daniel J Drucker; Joel K Elmquist
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

5.  Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

6.  Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

Authors:  Richard W Gelling; Patricia M Vuguin; Xiu Quan Du; Lingguang Cui; John Rømer; Raymond A Pederson; Margarita Leiser; Heidi Sørensen; Jens J Holst; Christian Fledelius; Peter B Johansen; Norman Fleischer; Christopher H S McIntosh; Erica Nishimura; Maureen J Charron
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

7.  OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas.

Authors:  A Vetere; W-C Li; F Paroni; K Juhl; L Guo; W Nishimura; X Dai; S Bonner-Weir; A Sharma
Journal:  Diabetologia       Date:  2009-10-31       Impact factor: 10.122

Review 8.  Peptide regulators of peripheral taste function.

Authors:  Cedrick D Dotson; Maartje C P Geraedts; Steven D Munger
Journal:  Semin Cell Dev Biol       Date:  2013-01-22       Impact factor: 7.727

Review 9.  New insights into the architecture of the islet of Langerhans: a focused cross-species assessment.

Authors:  Rafael Arrojo e Drigo; Yusuf Ali; Juan Diez; Dinesh Kumar Srinivasan; Per-Olof Berggren; Bernhard O Boehm
Journal:  Diabetologia       Date:  2015-07-28       Impact factor: 10.122

Review 10.  Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination?

Authors:  Melissa F Brereton; Elisa Vergari; Quan Zhang; Anne Clark
Journal:  J Histochem Cytochem       Date:  2015-08       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.